Cover Image
市場調查報告書

美國的寵物用醫藥品:第4版

Pet Medications in the U.S. - 4th Edition

出版商 Packaged Facts 商品編碼 217051
出版日期 內容資訊 英文 159 Pages
訂單完成後即時交付
價格
Back to Top
美國的寵物用醫藥品:第4版 Pet Medications in the U.S. - 4th Edition
出版日期: 2015年10月16日 內容資訊: 英文 159 Pages
簡介

美國寵物用醫藥品的銷售額規模預測在2015年為70億美金,到2019年預測將達到90億美金的規模。

本報告提供美國的寵物用醫藥品市場相關調查,提供您市場趨勢與未來的成長預測,零售趨勢,消費者趨勢等相關分析。

第1章 摘要整理

第2章 市場趨勢

  • 市場規模與結構
  • 美國的寵物用醫藥品零售預測在2015年達到70億美元
  • 動物別銷售額佔有率
  • 各流通管道銷售額佔有率
  • 市場預測
  • 獸醫市場
  • 未來展望
  • 市場成長預測:銷售額預測在2019年前將達到90億美元、其他

第3章 市場行銷

  • 競爭概要
  • 處方藥·非處方藥市場行銷
  • 零售寵物用醫藥品市場行銷
  • 關注的契約
  • 動物醫療上新興企業的趨勢
  • 抗寄生蟲藥的全球
  • OTC品牌藥在大流通管道中苦戰
  • 著重於Retail Flea/Tick Brands
  • 廣告·推銷的趨勢
  • 狗線狀蟲市場上變化
  • 開發中的市場區隔趨勢
  • 癌症
  • 腦的健康
  • 疼痛管理
  • 糖尿病
  • 心臟的健康
  • 耳朵感染疾病
  • 皮膚過敏、其他

第4章 零售趨勢

  • 全方位流通管道消費者的課題
  • 寵物所有者的寵物用醫藥品的使用和流通管道的選擇
  • 線上零售細分化
  • Vet-VIPPS表示壟斷領域
  • 線上動物用藥局
  • 大眾市場的零售業者寵物用醫藥品著重
  • 行動獸醫服務的出現
  • 跳蚤·扁虱對寵物專門流通管道來說重要、其他

第5章 消費者趨勢

  • 寵物用醫藥品的購買形態
  • 跳蚤·扁虱品牌的統計
  • 狗擁有家庭的68%使狗線狀醫治小兒疳積的藥
  • 寵物用醫藥品的心理學特徵
  • 獸醫/專家 vs. 商店產品的態度
  • 寵物用醫藥品的阻力和替代品、其他

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: LA5416197

The market for pet medications in the U.S. has entered a period of redefinition and renewal. Merial's Frontline Plus is still the market leader in flea and tick medication, but it has a number of copycat competitors, selling at far less than the now off-patent powerhouse. But Merial has managed to not only stem the losses, but also gain back share via a new flea and tick blockbuster, Nexgard. In other areas, Zoetis introduced a blockbuster of its own, the anti-itch drug APOQUEL, and has had trouble meeting demand. The industry has also enjoyed the entrance of a wave of animal health start-ups, and a number of new drugs appear to be on the horizon.

Long sold primarily in the veterinary clinic, pet medications can be found in a variety of channels. Still, many animal health companies sell exclusively to the veterinary channel, which has drawn scrutiny from the FTC.

The pet medication space has also seen considerable investment action, from the position taken in Zoetis by the hedge fund of activist investor William Ackman to the sale of Novartis Animal Health's assets to Elanco and Virbac.

In its fourth edition, Pet Medications in the U.S. analyzes the market for prescription and over-the-counter medications for dogs and cats, with a particular focus on brand-name products used by consumers and on antiparasitics. Areas covered include parasite prevention and control (flea, tick, heartworm, etc.), cancer, pain management, behavioral health, diabetes, cognitive dysfunction, heart health, ear care and allergies. The report provides in-depth coverage of competitive trends, new product trends and marketing activity, and draws on insights from other reports in Packaged Facts' extensive Pet Market Collection. Statistics provided include historical and projected market revenues, along with demographics and psychographics of pet med purchasers, based on data from sources including Simmons and Packaged Facts own pet owner surveys.

Scope

This report examines the consumer market for medications for dogs and cats, with a focus on products used by consumers. These include prescription, over-the-counter (aka "retail"), and ethical products (nonprescription medications whose distribution is restricted by the manufacturer to veterinarians). The primary focus of this report is on antiparasitics (flea, tick, heartworm, etc.), but it also covers market-shaping developments in other areas including cancer, cognitive dysfunction, mood disorder, pain management, and obesity/diabetes.Animal health products for production animals and horses are excluded from this market analysis, as are nutritional supplements for horses and companion animals, the latter of which are covered in Packaged Facts' February 2015 report, Pet Supplements in the U.S., 5th Edition.

Report Methodology

The information contained in this report was obtained from primary and secondary research. Primary research entailed informal interviews with leading manufacturers of pet medications and with other pet industry experts; attendance at the Global Pet Expo and Petfood Forum trade events from 2005 through 2015; consultations with pet product manufacturers and members of the trade; and an on-site examination of retail venues. Secondary research included extensive Internet canvassing and research- and data-gathering from relevant consumer business and trade publications; company reports including annual reports, press releases, and investor conference calls; company profiles in trade and consumer publications; government reports; and other pet market reports by Packaged Facts.

Sales estimates are based on published and estimated sales of major market participants; market size estimates from other sources appearing in the trade press; figures obtained through consultation with market participants; the performance of relevant retail venues; consumer usage rates for pet medications; rates of company and product entries into the market; and sales data from IRI for multi-outlet (MULO), which represents sales through U.S. supermarkets, drugstores, mass merchandisers (Walmart, Target, Kmart, and Shopko), Sam's Club and BJ's warehouse clubs, dollar stores excluding Dollar Tree, and military commissaries.

Our consumer analysis draws primarily on two sources:

  • Simmons National Consumer Surveys from Experian Marketing Services. On an ongoing basis, Experian Marketing Services conducts booklet-based surveys of a large and random sample of consumers (approximately 25,000 for each 12-month survey compilation) who in aggregate represent a statistically accurate cross-section of the U.S. population.

Packaged Facts Pet Owner Surveys, including one conducted in August 2015. These surveys had a sample of 2,000 U.S. respondents age 18 or over who in aggregate are Census representative on the primary demographic measures of gender, age bracket, race/ethnicity, geographic region, household income bracket, and presence of children in the household.

Table of Contents

Chapter 1: Executive Summary

  • Scope and Methodology
  • Market Definition
    • Product Regulation
  • Report Methodology
  • Market Trends
  • Market Size & Composition
  • U.S. Retail Sales of Pet Medications at $7 Billion in 2015
  • Share of Sales by Distribution Channel
    • Figure 1-1 Share of U.S. Retail Sales of Pet Medications by Distribution Channel, 2015 (percent)
  • Market Outlook
    • Table 1-1 Projected U.S. Retail Sales of Pet Medications, 2015-2019(in billions of dollars)
  • Competitive Overview
  • Prescription and Non-prescription Marketers
  • Shakeup in the Global Animal Health Rankings
    • Table 1-2 Global Pharmaceutical Marketers: Total Sales vs. Animal Health Sales, 2013-2014 (in millions of dollars)
  • Retail Pet Medication Marketers
  • Notable Deals
    • AmerisourceBergen Snaps Up MWI Veterinary Supply
    • VCA Buys Camp Bow Wow
    • Novartis Assets Divvied Up
    • Parnell Pharmaceuticals Goes Public
    • Jaguar Animal Health Runs to Public Markets
  • Merial Wards Off the Competition
  • Retail Trends
  • The Challenge of the Omnichannel Consumer
  • FTC Reports Examines Competition in Industry
  • Consumer Trends
  • Three-Quarters of Dog or Cat Households Use Flea/Tick Products
  • Pet Owners Still Favor Spot-On Flea/Tick Medications
  • 68% of Dog-Owning Households Use Heartworm Meds
    • Figure 1-2 Purchasing of Heartworm Medications by Channel, 2015(U.S. dog owners)
  • Antibiotics Top List of Other Pet Medications
  • Attitudes on Veterinarian/Professional vs. Store Products
    • Table 1-3 Levels of Agreement/Disagreement with Statement,"I Trust the Pet Medications My Veterinarian Recommends":Dog Owners vs. Cat Owners, 2015 (percent)

Chapter 2: Market Trends

  • Market Size & Composition
  • U.S. Retail Sales of Pet Medications at $7 Billion in 2015
    • Table 2-1 U.S. Retail Sales of Pet Medications, 2011-2015(in billions of dollars)
  • Share of Sales by Animal Type
    • Figure 2-1 Share of U.S. Retail Sales of Pet Medications by Animal Type: Dog vs. Cat, 2015 (percent)
  • Share of Sales by Distribution Channel
    • Figure 2-2 Share of U.S. Retail Sales of Pet Medications by Distribution Channel, 2015 (percent)
    • Table 2-2 Share of U.S. Sales of Pet Medications by Type, 2015(percent)
  • Market Outlook
  • The Veterinary Market
  • Industry Banks on Higher-Income Households
    • Figure 2-3 $70K+ Household Share of U.S. Pet Market Expenditures: By Category, 2003 vs. 2013 (percent)
  • Pets Are No Spring Chickens
    • Table 2-3 Age of Dogs and Cats, 2015 (percent of pet owners)
    • Figure 2-4 Percentage of Dogs and Cats Age 6 and Over, 1987 vs. 2011 (percent)
  • Overweight Pets at Risk
    • Table 2-4 Agreement With Statement: "I have an overweight dog/cat," 2014 vs. 2015 (percent)
  • Morris Animal Foundation a Primary Research Funder
  • IBM's Watson to Advise Veterinarians
  • Pet Insurance Making Strides
    • Figure 2-5 Projected North American Pet Insurance Market Revenues: United States, Canada, and North America, 2013 vs. 2018 (in millions of U.S. dollars)
  • Optimism in Economy Increases, But Consumers Still Wary
  • Some Consumers Still Spending Less
    • Table 2-5 Level of Agreement with Statement: "I am spending less on pet products because of the economy," 2010-2015 (percent)
    • Table 2-6 Economic Mood of U.S. Pet Households, 2011-2015 (percent)
    • Table 2-7 Economic Outlook of U.S. Pet Households, 2011-2015 (percent)
  • Veterinary Visit Statistics
    • Table 2-8 Percentage of Dog and Cat Owners Who Have Visited Vet in Past Year: Routine Checkup vs. Sick/Emergency Care, 2015 (percent)
  • Veterinary Prices Rising or Falling?
  • Industry Attempts to Reverse Trend
  • Updates on Bayer Veterinary Care Usage Study
  • Veterinarians a Key Source for Parasite Prevalence
  • Information
  • Holistic and Natural Treatments
    • Table 2-9 Use of Specialty Nutritional Formula Pet Food, Treats, and Pet Supplements, Last 30 Days: Dog Owners vs. Cat Owners, 2015 (percent)
  • Looking Ahead
  • Projected Market Growth: Sales to Close in on $9 Billion by 2019
    • Table 2-10 Projected U.S. Retail Sales of Pet Medications, 2015-2019 (in billions of dollars)

Chapter 3: The Marketers

  • Competitive Overview
  • Prescription and Non-prescription Marketers
  • Shakeup in the Global Animal Health Rankings
    • Table 3-1 Global Pharmaceutical Marketers: Total Sales vs. Animal Health Sales, 2013-2014 (in millions of dollars)
    • Table 3-2 Global Pharmaceutical Marketers by Dollar and Percentage Change in Global Sales: Total vs. Animal Health, 2013-2014 (in millions of dollars)
    • Table 3-3 Global Pharmaceutical Marketers by Dollar and Percentage Change in Global Sales: Animal Health, 2015 (projected) (in millions of dollars)
  • Retail Pet Medication Marketers
  • Notable Deals
    • AmerisourceBergen Snaps Up MWI Veterinary Supply
    • VCA Buys Camp Bow Wow
    • PetSmart Makes a Web Play
    • Petco Increases Pet Health Reach with Drs. Foster & Smith Purchase
    • Petco Files for IPO
    • Novartis Assets Divided Up
    • Interest in Zoetis
    • Parnell Pharmaceuticals Goes Public
    • Jaguar Animal Health Runs to Public Markets
    • Veterinary Practice Businesses Change Owners
    • H.I.G. Capital Creates Community Veterinary Clinics, LLC
    • Shore Capital Jumps into Veterinary Market
    • More Veterinary Practices Consolidate
  • Wave of Animal Health Startups
  • Generics Still Trying to Make In-Roads
    • Generics Continue Assault of the Frontline Franchise
    • Putney Keeps the Generics Coming
    • Illustration 3-1 Trade Ad for Putney's Carprofen Chewable Tablets
    • Putney Surveys Veterinarians About Generics
    • Norbrook Also a Generics Player
    • Illustration 3-2 Trade Ad for Norbrook's Carprieve Injection
  • The World of Antiparasitics
  • Merial Still Tops the Flea/Tick Charts
    • Table 3-4 Marketer Shares of U.S. Flea & Tick Sales, 2015 (percent)
  • Merial Wards Off the Competition
    • Illustration 3-3 Screenshot from Frontline Plus Commercial
  • Bayer's Lineup Packs a Punch
    • Advantage's History in the Trade
  • Zoetis Eyes a Bigger Slice of Parasiticide Market
  • Elanco's Growth
  • Virbac Adds to U.S. Offerings
  • Ceva Picks Up Growth
    • Merck Adds Chewable to Product Line
    • Illustration 3-4 Trade Ad Introducing Merck's Bravecto
  • OTC Brands Struggle in Mass Channels
    • Table 3-5 IRI-tracked Sales of Pet Medications, 2015
    • Table 3-5 [cont'd] IRI-tracked Sales of Pet Medications, 2015
    • Table 3-5 [cont'd] IRI-tracked Sales of Pet Medications, 2015
  • Focus on Retail Flea/Tick Brands
    • Central Garden & Pet Performance
    • Illustration 3-5 Screen shot of Bio Spot Active Care website
    • Hartz Campaign Focuses on Year-Round Protection
    • Perrigo Launches Frontline Plus Versions
    • Illustration 3-6 Screenshot of PetArmor's Website Touting PetArmor Plus
    • Other Frontline Plus Copycats Emerge
    • Illustration 3-7 Screenshot of PetAction Plus Ad
    • Illustration 3-8 Screenshots of PetArmor Plus Ad
    • Illustration 3-9 Spectra Sure Floor Display
  • Trends in Advertising and Promotion
    • Bayer
    • Illustration 3-10 Bayer's K9s For Warriors Campaign
    • Illustration 3-11 Banner Ad for Seresto
    • Perrigo
    • Central Garden & Pet
    • Illustration 3-12 Adams Smart Pets Contest
    • Ceva Animal Health
    • Illustration 3-13 Screen Shot from Vectra 3D Video
    • Elanco
    • Illustration 3-14 Screenshot of Elanco's Celebrate the Bond Website
    • Hartz
    • Merial
    • Illustration 3-15 Buzzfeed Channel for Frontline Plus
    • Illustration 3-16 Screen shot from NexGard "Doggone Funny" Video
  • Changes in Heartworm Market
  • Virbac Joins Big Leagues
  • Elanco Brings Back Interceptor
    • Illustration 3-17 Trade Ad for Interceptor
  • Heartgard Keeps Rolling
  • Heartworm Advertising and Promotion
    • Illustration 3-18 Screen shot for Merial's IHeartgardMyDog.com
    • Illustration 3-19 Two-page trade ad for Virbac's Heartworm Products
  • Broad Spectrum Wormers
    • Illustration 3-20 Trade Ad for Profender
  • Trends in Developing Market Segments
  • Cancer
  • Brain Health
  • Pain Management
    • Major Brands
    • Illustration 3-21 Banner Ad for Bayer's Quellin (Carprofen)
    • Illustration 3-22 Trade Ad for Metacam
    • Illustration 3-23 Trade Ad for Merial's Previcox
    • Illustration 3-24 Banner Ad for the Rimadyl K9 Courage Program
    • Illustration 3-25 Trade Ad for Simbadol
  • Diabetes
    • Illustration 3-26 Trade Ad for Vetsulin
  • Heart Health
    • Illustration 3-27 Trade Ad for Boehringer Ingelheim Vetmedica's Vetmedin
  • Ear Infections
    • Illustration 3-28 Trade Ad for Merial's Tresaderm
    • Illustration 3-29 Trade Ad for Elanco Earnings Mentioning Surolan
  • Skin Allergies
    • Illustration 3-30 Banner Ad for Convenia's My Pet Itches Website
    • Illustration 3-31 Atopica for Cats Website

Chapter 4: Retail Trends

  • The Challenge of the Omnichannel Consumer
  • FTC Reports Examines Competition in Industry
  • Pet Meds Use and Channel Choices Among Pet Adopters
  • Online Retail Appears Fragmented
    • Illustration 4-1 Newspaper Free-Standing Insert for PetCareRx.com
  • Vet-VIPPS Marks Exclusive Territory
  • Veterinary Pharmacies Online
    • Illustration 4-2 Vets First Choice Trade Ad
  • PetMed Express Sees Slow Growth
    • Illustration 4-3 Screenshot from 1-800-PetMeds' TV Commercial
    • Table 4-1 PetMed Express Sales, 2007-2015 (in millions of dollars)
  • PetSmart and Petco Step Up Web Game
    • Illustration 4-4 Banner on Petco.com Home Page Touting Doctors Foster and Smith
    • Illustration 4-5 Pet360 Information Page on PetSmart.com
  • Mass Market Retailers Emphasize Pet Meds
    • Illustration 4-6 Endcap of Pet Aisle at Sam's Club
  • Mobile Veterinary Services Popping Up
    • Illustration 4-7: Left: Vaccination Clinic Announcement in Front of Tractor Supply Company; Right: Vaccination Cooler at Tractor Supply Company
  • Fairness to Pet Owners Act Still on the Table
  • Flea & Tick Important to Pet Specialty Channel
    • Illustration 4-8 Screenshot from PetSmart Flea & Tick Ad
    • Illustration 4-9 Screenshot from Petco Ad Featuring Bayer and TruRx Products
    • Illustration 4-10 Flea & Tick Section from Pet Supplies Plus June-July 2015 Flyer
    • Illustration 4-11 Screenshot for Sentry Fiproguard Plus Ad

Chapter 5: Consumer Trends

  • Pet Medication Purchasing Patterns
  • Three-Quarters of Dog or Cat Households Use Flea/Tick Products .. 133
    • Table 5-1 Percent of Dog or Cat Owners Who Purchase Flea & Tick Care Medications or Medicated Products, 2012-2015 (U.S. dog- or cat-owning households in thousands)
  • Pet Owners Still Favor Spot-On Flea/Tick Medications
    • Figure 5-1 Purchasing of Flea & Tick Care Medications: Share by Product Type, 2015 (percent of U.S. dog or cat owners)
    • Figure 5-2 Purchasing of Spot-On Flea & Tick Care Medication by Channel, 2015 (U.S. dog or cat owners)
  • Frontline Still the Top Draw, But Brand Usage More Varied
    • Table 5-2 Share of Flea & Tick Care Medication Purchasers by Brand, 2015 (U.S. dog owners)
    • Table 5-3 Share of Flea & Tick Care Topical Medication Purchasers by Brand, 2015 (U.S. cat owners)
  • Demographics for Flea & Tick Brands
    • Table 5-4a Index for Use of Flea/Tick Products by Brand, 2015
    • Table 5-4a [Cont.] Index for Use of Flea/Tick Products by Brand, 2015 (U.S. dog- or cat-owning households)
    • Table 5-4a [Cont.] Index for Use of Flea/Tick Products by Brand, 2015 (U.S. dog- or cat-owning households)
    • Table 5-4b Index for Use of Flea/Tick Products by Brand, 2015
    • Table 5-4b [cont'd] Index for Use of Flea/Tick Products by Brand, 2015
    • Table 5-4b [cont'd] Index for Use of Flea/Tick Products by Brand, 2015
  • 68% of Dog-Owning Households Use Heartworm Meds
    • Table 5-5 Index for Use of Heartworm Control Medications for Dogs, 2015
    • Table 5-5 [cont'd] Index for Use of Heartworm Control Medications for Dogs, 2015
    • Table 5-5 [cont'd] Index for Use of Heartworm Control Medications for Dogs, 2015
    • Figure 5-3 Purchasing of Heartworm Medications by Channel, 2015 (U.S. dog owners)
  • Dog Owners Prefer Heartgard
    • Table 5-6 Share of Heartworm Purchasers by Brand, 2015 (U.S. dog owners)
  • Antibiotics Top List of Other Pet Medications
    • Table 5-7 Use by Type of Selected Other Pet Medications for Dogs and Cats, 2015 (percent)
    • Table 5-8 Purchasing by Channel of Selected Other Pet Medications for Dogs, 2015 (percent)
    • Table 5-9 Purchasing by Channel of Selected Other Pet Medications for Cats, 2015 (percent)
  • For Flea/Tick, Veterinarians and Walmart Key for Dog Owners
    • Table 5-10 Purchasing of Flea/Tick Care Medications by Channel: Dog Owners, 2015 (percent)
  • Internet Favorites Differ By Prescription and Non- Prescription
    • Table 5-11 Purchasing of Prescription Dog and Cat Medications by Online Source, 2015 (percent)
    • Table 5-12 Purchasing of Non-Prescription Dog and Cat Medications by Online Source, 2015 (percent)
  • Pet Med Psychographics
  • Pet Owners Keep Pet Med Purchases Consistent
    • Table 5-13 Levels of Agreement/Disagreement with Statement, "I Am Buying More Pet Medications Than I Used To": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-14 Levels of Agreement/Disagreement with Statement "The Current Range of Pet Medications Is Not Adequate": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-15 Levels of Agreement/Disagreement with Statement, "I Am Interested in New Types of Pet Medications": Dog Owners vs. Cat Owners, 2015 (percent)
  • Pet Owners See Age- and Weight-Related Causes
    • Table 5-16 Levels of Agreement/Disagreement with Statement, "Age-Related Conditions Are the Cause of Some of the Pet Medications That I Buy": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-17 Levels of Agreement/Disagreement with Statement, "Weight/Obesity-Related Conditions Are the Cause of Some of the Pet Medications That I Buy": Dog Owners vs. Cat Owners, 2015 (percent)
  • Attitudes on Veterinarian/Professional vs. Store Products
    • Table 5-18 Levels of Agreement/Disagreement with Statement, "I Trust the Pet Medications My Veterinarian Recommends": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-19 Levels of Agreement/Disagreement with Statement, "I Trust the Pet Medications Available at the Stores Where I Buy Pet Products": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-20 Levels of Agreement/Disagreement with Statement, "With Spot-On (Topical) Flea/Tick Products, the Products Available in Stores Are Just as Effective as Those Available Through Veterinarians": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-21 Levels of Agreement/Disagreement with Statement, "With Spot-On (Topical) Flea/Tick Products, I Would Trust Generic or Store-Brand Products if They Contained the Same Active Ingredients": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-22 Levels of Agreement/Disagreement with Statement, "Veterinarian-Dispensed Spot-On (Topical) Flea/Tick Products Are Too Expensive": Dog Owners vs. Cat Owners, 2015 (percent)
  • Resistance and Alternatives to Pet Meds
    • Table 5-23 Levels of Agreement/Disagreement with Statement, "I Avoid Using Pet Medications as Much as Possible": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-24 Levels of Agreement/Disagreement with Statement, "I Prefer to Try Holistic/Natural Pet Treatments Including Nutritional Supplements Before Resorting to Pet Medications": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-25 Levels of Agreement/Disagreement with Statement, "High-Quality Pet Foods Are Effective as a Preventive Pet Health Treatment": Dog Owners vs. Cat Owners, 2015 (percent)
Back to Top